CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Infinity Pharmaceuticals, Inc. (NAS: INFI) today announced that the company amended its development and license agreement with Millennium: The Takeda Oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results